CARTICEL (Vericel Corporation)


Welcome to the PulseAid listing for the CARTICEL drug offered from Vericel Corporation. This Autologous Cultured Cell [EPC],Cells, Cultured, Autologous [Chemical/Ingredient],Chondrocytes [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.




LABELER NAME / MANUFACTURER: Vericel Corporation
NON-PROPRIETARY NAME: autologous cultured chondrocytes
SUBSTANCE NAME: AUTOLOGOUS CULTURED CHONDROCYTES
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Autologous Cultured Cell [EPC],Cells, Cultured, Autologous [Chemical/Ingredient],Chondrocytes [Chemical/Ingredient]
ROUTE: INTRA-ARTICULAR
DOSAGE FORM: IMPLANT
MARKETING CATEGORY NAME: BLA
START MARKETING DATE: 1905-06-19
END MARKETING DATE: 0000-00-00


CARTICEL HUMAN PRESCRIPTION DRUG Details:

Item DescriptionCARTICEL from Vericel Corporation
LABELER NAME: Vericel Corporation
DEA SCHEDULE:
ACTIVE STRENGTH: 12000000(1-Jan)
START MARKETING DATE: 1905-06-19
END MARKETING DATE: 0000-00-00
PRODUCT ID: 69866-1025_45501f23-533e-4c7a-9203-2974d40c8a26
PRODUCT NDC: 69866-1025
APPLICATION NUMBER: BLA103661

Other AUTOLOGOUS CULTURED CHONDROCYTES Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Genzyme CorporationCarticel
Vericel CorporationCARTICEL